|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
41st Annual Anatomic Pathology Conference
Feb. 13-15, 2015 at Disney's Contemporary Resort in Orlando, Florida
You are invited to join the Florida Society of Pathologists at the 41st Annual Anatomic Pathology Conference at Disney's Contemporary Resort® in beautiful Lake Buena Vista, Florida!
Real-time genome sequencing helps control hospital outbreak
Pioneering use of whole genome sequencing in real time to help control a hospital outbreak is reported in an article published in the open access journal Genome Medicine. The research corroborates the use of the technique as a rapid and cost-effective way of tracking and controlling the spread of drug-resistant hospital pathogens.
Whistleblower lawsuits at US clinical pathology laboratories are rising
Whistleblower activity across the medical laboratory industry seems to be increasing. This can be both a positive and a negative trend for pathologists and clinical laboratory managers. On the positive side, a whistleblower lawsuit that is joined by the U.S. Department of Justice and state attorney generals is one way to curb the illegal marketing and business practices of those medical lab companies willing to gain a competitive market advantage by pushing their interpretation of federal and state laws beyond legal limits.
Why are drug costs so high in the United States?
The United States has the dubious honor of paying the highest costs for drugs in the world, even compared with other wealthy nations, such as Canada, Germany, and Japan. The difference in price can often be substantial, especially among the newer and very costly agents that have recently come on the market.
In this in-depth feature, Medscape Medical News examines the reasons for this. The story starts at a "watershed" moment two years ago.
New biomarker detects and treats cancer tumors at same time
Scientists at Singapore's Nanyang Technological University have created a new biological marker for cancer patients that lights up tumor cells and treats disease with drugs at the same time. The breakthrough biomarker is a nanophosphor particle ten thousand times smaller than a grain of sand, which lights up when it detects tumor cells to allow scientists to take a better look.
Report: Florida has worst physician shortage
Despite recent suggestions that concerns about the primary care physician shortage may be overblown, the problem is especially pronounced at the state level, with Florida coming up shortest, according to a new report from the Kaiser Family Foundation.
Changing the culture to one of safety
The frequency of both serious and fatal lab accidents in academic chemistry labs in the past few years has become increasingly alarming. Recent high-profile incidents have thrust lab safety into the mainstream spotlight, and have illustrated the fact that many current university safety guidelines and systems are inadequate. Both the National Research Council and U.S. government have responded to the crisis — one with a report and recommended action steps, and the other with a new policy to take effect September 2015.
'Blind spots' in DNA may conceal cancer genes
Medical News Today
Although gene-reading technology is advanced and sophisticated, there are certain parts of DNA that it does not cope with perfectly; for instance, there are repetitive areas of DNA that cause the machinery to "stutter." But there is a way to examine these "blind spots" and discover if they conceal cancer genes.
Medicare price cuts may slow total overall hospital spending growth
Contrary to the predictions of some analysts, a recent study suggests that slowing Medicare price growth by lowering hospital reimbursements will slow hospital utilization and spending for all age groups. For pathologists and clinical laboratory managers, the study represents credible evidence that cuts in Medicare prices cause a measurable and linked decrease in hospital utilization for both the elderly and the non-elderly.
Disclaimer: The authors, editors, and the Florida Society of Pathologists (FSP) Executive Committee affiliated with "Florida Pathology Today" e-Newsletter cannot and do not warrant the completeness, accuracy, non-infringement, merchantability, timeliness or fitness for a particular purpose of the information or views contained within this publication, or available through the links provided within articles contained within this publication.
FSP has no control over and does not officially endorse the content of the information available on the links contained in the "Florida Pathology Today" or links imbedded in articles within the "Florida Pathology Today." These links are provided as a courtesy only. Linked sites are not a part of the "Florida Pathology Today." The owners of those linked sites, and not FSP, own the intellectual property rights to the material on the linked sites. FSP cannot certify the accuracy of material published on linked sites. Additionally, the contents of this e-Newsletter and the above referenced links, including any advice, suggestions, and/or recommendations have NOT been generated as part of any professional evaluation.
The authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" e-Newsletter shall not be liable to anyone for any loss or injury caused in whole or in part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting or delivering this e-Newsletter and any information included in this e-Newsletter.
Under no circumstances will the authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" be liable to you or anyone else for any decision made or any action taken by you or anyone else in reliance on such information or view, or for any incidental, consequential, special, or similar damages even if advised of the possibility of such damages.
The above warranties are the only warranties of any kind either expressed or implied, including warranties of merchantability or fitness for any particular purpose.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063